Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
5 Downloads (Pure)


The emerging pathogen Campylobacter concisus has been isolated from patients with gastrointestinal diseases; however, it is also present in the gut of healthy individuals. The aim of this study was to compare IL-8 production in HT-29 cells after infection with C. concisus from different gastrointestinal disease phenotypes. Additionally, to investigate whether differentiation of isolates in genomospecies (GS1 and GS2) or presence of the zot gene, encoding the Zot toxin, affects IL-8 production. A total of 37 C. concisus isolates from patients with microscopic colitis (n = 20), ulcerative colitis (n = 5), Crohn's disease (n = 5), diarrhoea (n = 2) and from healthy controls (n = 5) were used. Intestinal HT-29 cells were infected and incubated for 24 h. Supernatants were subsequently removed and analysed for IL-8 by MILLIPLEX. All isolates were able to stimulate IL-8 production and IL-8 levels were higher than in non-infected HT-29 cells. No difference was observed between disease phenotypes or GS1 and GS2, whereas presence of the zot gene showed a tendency towards higher IL-8 production. Further investigations in other inflammatory and physiological models are needed to conclude whether C. concisus strains from different gastrointestinal disease phenotypes differ in pathogenic potential and play a part in gastrointestinal disease.

Original languageEnglish
Article number5
JournalGut Pathogens
Issue number1
Publication statusPublished - 13 Feb 2023

Bibliographical note

© 2023. The Author(s).


  • Campylobacter concisus
  • Inflammatory bowel diseases
  • Interleukin-8
  • Microscopic colitis
  • Pathogenesis


Dive into the research topics of 'Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells'. Together they form a unique fingerprint.

Cite this